An ex-vivo angiogenesis assay as a screening method for natural compounds and herbal drug preparations

Planta Medica

Volumn 70, Issue 10, 2004, Pages 887-892

  Baróniková, Slávka ^a   Apers, Sandra ^a   Vanden Berghe, Dirk ^a   Cos, Paul ^a   Vermeulen, Peter ^b,c   Van Daele, André ^b   Pieters, Luc ^a   Van Marck, Eric ^b   Vlietinck, Arnold ^a  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^c SINT AUGUSTINUS HOSPITAL   (Belgium)

Author keywords

Aesculus hippocastanum; Angiogenesis; Camellia sinensis; Endothelial outgrowth; Ex vivo assay; Green tea; Herbal drug preparations; Horse chestnut; Natural compounds; Olea europaea; Olive tree; Validation

Indexed keywords

5 AMINO 1 [3,5 DICHLORO 4 (4 CHLOROBENZOYL)BENZYL] 1H 1,2,3 TRIAZOLE 4 CARBOXAMIDE; AESCULUS HIPPOCASTANUM EXTRACT; ANGIOGENESIS INHIBITOR; BASIC FIBROBLAST GROWTH FACTOR; DIMETHYL SULFOXIDE; FIBRIN; GREEN TEA EXTRACT; HERBACEOUS AGENT; NATURAL PRODUCT; OLIVE TREE EXTRACT; PLANT EXTRACT; UNCLASSIFIED DRUG;

AESCULUS HIPPOCASTANUM; ANGIOGENESIS; ARTICLE; BIOASSAY; CONTROLLED STUDY; CULTURE MEDIUM; DRUG SCREENING; EX VIVO STUDY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; OLIVE TREE; PLACENTA; QUANTITATIVE ANALYSIS; TEA; VALIDATION PROCESS; VASCULAR ENDOTHELIUM; WOUND HEALING;

AESCULUS; ANGIOGENESIS INHIBITORS; CAMELLIA SINENSIS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG EVALUATION, PRECLINICAL; FIBROBLAST GROWTH FACTORS; HUMANS; NEOVASCULARIZATION, PHYSIOLOGIC; OLEA; PHYTOTHERAPY; PLANT EXTRACTS; PLANTS, MEDICINAL; REPRODUCIBILITY OF RESULTS; TRIAZOLES;

AESCULUS; AESCULUS HIPPOCASTANUM; CAMELLIA; CAMELLIA SINENSIS; EQUUS CABALLUS; OLEA EUROPAEA;

EID: 7644227650     PISSN: 00320943     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-832611     Document Type: Article

References (25)

1. Folkman J. Clinical applications of research in angiogenesis. N Eng J Med 1995; 333: 1757-63
2. Nakopoulou L, Stefanaki K, Panayotopoulou E, Giannopoulou I, Athanassiadou P, Gakiopoulou-Givalou H, Louvrou A et al. Expression of the vascular endothelial growth factor receptor-2/Flk-1 in breast carcinomas: Correlation with proliferation. Hum Pathol 2002; 33: 863-70
3. Gimbrone Jr MA, Cotran RS, Leapman SB, Folkman J. Tumor growth and neovascularization: an experimental model using the rabbit cornea. J Natl Cancer Inst 1974; 52: 413-27
4. Andrade SP, Fan TP, Lewis GP. Quantitative in vivo studies in angiogenesis in a rat sponge model. Br J Exp Pathol 1987; 68: 755-66
5. Folkman J. Tumor angiogenesis. Adv Cancer Res 1974; 19: 331-58
6. Vailhé B, Vittet D, Feige J-J. In vitro models of vasculogenesis and angiogenesis. Lab Invest 2001; 81: 439-52
7. Nicosia RF, Ottinetti A. Growth of microvessels in serum-free matrix culture of rat aorta. Lab Invest 1990; 63: 115-55
8. Masson V, Devy L, Grígnet-Debrus Ch, Bernt S, Bajou K, Blacher S, Roland G, Chang Y, Fong T, Carmeliet P, Foidart J-M, Noël A. Mouse aortic ring assay: a new approach of the molecular genetics of angiogenesis. Biol Proceed Online 2002; 4: 24-31
9. Brown K, Maynes S, Bezos A, Maguire DJ, Ford MD, Parish CR. A novel in vitro assay for human angiogenesis. Lab Invest 1996; 75: 539-55
10. Sahni A, Francis CW. VEGF binds to fibrinogen and fibrin and stimulates endothelial cell proliferation. Blood 2000; 96: 3772-8
11. Watson JC, Redmann JG, Meyers MO, AlperinLea RC, Gebhardt BM, Delcarpio JB, Woltering EA. Breast cancer increases initiation of angiogenesis without accelerating neovessel growth rate. Surgery 1997; 122: 508-14
12. Alessandri G, Girelli M, Taccagni G, Colombo A, Nicosia R, Caruso A, Baronio M, Pagano S, Cova L, Parati E. Human vasculogenesis ex vivo: embryonal aorta as a tool for isolation of endothelial cell progenitors. Lab Invest 2001; 81: 875-85
13. Conn G, Soderman DD, Schaeffer MT, Wile M, Hatcher VB, Thomas KA. Purification of a glycoproein vascular endothelial cell mitogen from a rat glioma-derived cell line. Proc Natl Acad Sci USA 1990; 87: 1323-7
14. Kohn EC, Felder CC, Jacobs W, Holmes KA, Day A, Freer R, Liotta LA. Structure function analysis of signal and growth inhibition by carboxyamidotriazole, CAl. Cancer Res 1997; 54: 935-42
15. Bikfalvi A, Klein S, Pintucci G, Rifkin DB. Biological roles of fibroblast growth factor-2. Endocr Rev 1997; 18: 26-45
16. Basilico C, Moscatelli D. The FGF family of growth factors and oncogenesis. Adv Cancer Res 1992; 59: 115-65
17. Imai K, Suga K, Nakachi K. Cancer-preventive effects of drinking tea among a Japanese population. Prev Med 1997; 26: 769-75
18. Cao Y, Cao R. Angiogenesis inhibited by drinking tea. Nature 1999; 398: 381
19. Kojima-Yuasa A, Jin Hua J, Kennedy DO, Matsui-Yuasa I. Green tea extract inhibits angiogenesis of human umbilical vein endothelial cells through reduction of expression of VEGF receptors. Life Sci 2003; 93: 1299-313
20. Lamy S, Gingras D, Béliveau R. Green tea catechins inhibit vascular endothelial growth factor receptor phosphorylation. Cancer Res 2002; 62: 381-5
21. Jankun J, Selman SH, Swiercz R, Skrzypczak-Jankun E. Why drinking green tea could prevent cancer. Nature 1997; 387: 561
22. Maeda-Yamamoto M, Kawahara H, Tahara N, Tsuji K, Hara Y, Isemura M. Effects of tea polyphenols on the invasion and matrix metalloproteinases activities of human fibrosarcoma HT 1080 cells. J Agric Food Chem 1999; 47: 2350-4
23. Okabe S, Suganuma M, Hayashi M, Sueoka E, Komori A, Fujiki H. Mechanisms of growth inhibition of human lung cancer cell line, PC-9, by tea polyphenols. Int J Cancer 1997; 88: 639-43
24. Carluccio MA, Sicuella L, Ancora MA, Massaro M, Scoditti E, Storelli C, Visioli F, Distante A, De Caterina R. Olive oil and red wine antioxidant polyphenols inhibit endothelial activation: antiatherogenic properties of Mediterranean diet phytochemicals. Arterioscler Thromb Vase Biol 2003; 23: 622-9
25. Sirtori CE. Aescin: Pharmacology, pharmacokinetics and therapeutic profile. Pharmacol Res 2001; 44: 183-93